{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:58:34Z","timestamp":1753876714962,"version":"3.41.2"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We evaluated the diagnostic performance of the \u03b2-d-glucan (BDG) test (Beijing Gold Mountain River Tech) in diagnosing invasive fungal disease (IFD) and its variations among patients with different risks. Patients\u00a0\u226518 years old who underwent a serum BDG test (positive cutoff value\u00a0&amp;gt;80 pg\/ml) from April 2017 through May 2018 were collected consecutively. Patients were classified into three groups: group 1, patients with host factors as defined by the prior 2008 European Organization for Research and Treatment (EORTC) criteria; group 2, those with extended host factors in 2020 EORTC criteria; and group 3, those without any risk factor mentioned in the criteria. IFD was defined by 2020 EORTC criteria, but BDG was not considered. Diagnostic performance of the serum BDG test was measured by the area under the curve (AUC) of the receiver-operating characteristic curve. Among 469 patients, 15.4% (72\/469) were diagnosed with IFD (48\/191 [25.1%], 14\/144 [9.7%], and 10\/134 [7.5%] in groups 1, 2, and 3, respectively). The BDG assay showed fair performance (AUC 0.748 [95% CI: 0.688\u20130.810]). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 77.8%, 60.7%, 26.4%, and 93.8%, respectively. PPV was higher in group 1, and NPV was higher in group 3. Additionally, diagnostic odds ratios were 6.73, 2.88, and 5.92 in groups 1, 2, and 3. Immunosuppressant use, non-IFD\/Candida colonization, and central venous catheter were associated with false positivity. Clinicians should cautiously interpret the BDG assay, considering the various diagnostic performances depending on the different levels of risk.<\/jats:p>","DOI":"10.1093\/mmy\/myae071","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T02:18:27Z","timestamp":1721441907000},"source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic performance of the (1-3)-\u03b2-<scp>d<\/scp>-glucan assay in patients with different risks for invasive fungal diseases"],"prefix":"10.1093","volume":"62","author":[{"given":"Eliel","family":"Nham","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-8940","authenticated-orcid":false,"given":"Si-Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Changwon , Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-3964","authenticated-orcid":false,"given":"Kyungmin","family":"Huh","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-9780","authenticated-orcid":false,"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"2","key":"2024080613305710300_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciab336","article-title":"Mortality trends in risk conditions and invasive mycotic disease in the United States, 1999\u20132018","volume":"74","author":"Rayens","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/jof5010009","article-title":"New concepts in diagnostics for invasive mycoses: non-culture-based methodologies","volume":"5","author":"Patterson","year":"2019","journal-title":"J Fungi"},{"key":"2024080613305710300_bib3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De\u00a0Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","article-title":"\u03b2-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"39","author":"Odabasi","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib6","doi-asserted-by":"crossref","first-page":"e24651","DOI":"10.2196\/24651","article-title":"Candidemia risk prediction (CanDETEC) model for patients with malignancy: model development and validation in a single-center retrospective study","volume":"9","author":"Yoo","year":"2021","journal-title":"JMIR Med Inform"},{"key":"2024080613305710300_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10096-011-1365-0","article-title":"Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-\u03b2-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease","volume":"31","author":"Acosta","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024080613305710300_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib9","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/JCM.00673-15","article-title":"Evaluation of a novel plasma (1,3)-\u03b2-d-glucan detection assay for diagnosis of candidemia in pediatric patients","volume":"53","author":"Liu","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024080613305710300_bib10","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1200\/JCO.2008.20.1178","article-title":"Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation","volume":"27","author":"Michallet","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"2024080613305710300_bib11","doi-asserted-by":"crossref","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2024080613305710300_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/IDR.S181489","article-title":"Performance evaluation of the (1,3)-\u03b2-d-glucan detection assay in non-intensive care unit adult patients","volume":"12","author":"Murri","year":"2019","journal-title":"Infect Drug Resist"},{"key":"2024080613305710300_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/mmy\/myu066","article-title":"Serum (1,3)-\u03b2-d-glucan is an inefficient marker of breakthrough candidemia","volume":"52","author":"Abe","year":"2014","journal-title":"Med Mycol"},{"key":"2024080613305710300_bib14","doi-asserted-by":"crossref","first-page":"e0188860","DOI":"10.1371\/journal.pone.0188860","article-title":"Diagnostic performance of the (1-3)-\u03b2-d-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers","volume":"12","author":"Son","year":"2017","journal-title":"PLoS One"},{"key":"2024080613305710300_bib15","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","article-title":"Evaluation of a (1\u21923)-\u03b2-d -glucan assay for diagnosis of invasive fungal infections","volume":"43","author":"Pickering","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2024080613305710300_bib16","doi-asserted-by":"crossref","first-page":"ofu105","DOI":"10.1093\/ofid\/ofu105","article-title":"Detection of high cerebrospinal fluid levels of (1\u21923)-\u03b2-d-glucan in cryptococcal meningitis","volume":"1","author":"Rhein","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"2024080613305710300_bib17","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1086\/588295","article-title":"Reappraisal of the srum (1\u21923)-\u03b2-d-glucan assay for the diagnosis of invasive fungal infections\u2014a study based on autopsy cases from 6 years","volume":"46","author":"Obayashi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3-\u03b2-d-glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2024080613305710300_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/myc.12432","article-title":"1,3-\u00df-d-glucan concentrations in blood products predict false positive post-transfusion results","volume":"59","author":"Liss","year":"2016","journal-title":"Mycoses"},{"key":"2024080613305710300_bib20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","article-title":"Diagnostic performance of the (1\u21923)-\u03b2-d-glucan assay for invasive fungal disease","volume":"49","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024080613305710300_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JCM.03018-14","article-title":"Contribution of (1,3)-\u03b2-d-glucan to diagnosis of invasive candidiasis after liver transplantation","volume":"53","author":"Levesque","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2024080613305710300_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","article-title":"Difficulties in using 1,3-\u03b2-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies\u2014high frequency of false-positive results and their analysis","volume":"59","author":"Racil","year":"2010","journal-title":"J Med Microbiol"},{"key":"2024080613305710300_bib23","first-page":"306","article-title":"Role of (1-3)-\u03b2-d-glucan test in the diagnosis of invasive fungal infections among high-risk patients in a tertiary care hospital","volume":"14","author":"Sandhar","year":"2022","journal-title":"J Lab Phys"},{"key":"2024080613305710300_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"key":"2024080613305710300_bib25","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/IDR.S405810","article-title":"Epidemiology and factors associated with treatment success of invasive fungal infections among newly hematologic malignancy patients receiving chemotherapy or hematopoietic stem cell transplant in Thailand","volume":"16","author":"Weeraphon","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2024080613305710300_bib26","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.3324\/haematol.2016.151837","article-title":"Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study","volume":"102","author":"Tisi","year":"2017","journal-title":"Haematologica"},{"key":"2024080613305710300_bib27","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00658-06","article-title":"Reactivity of (1\u21923)-\u03b2-d-glucan assay with commonly used intravenous antimicrobials","volume":"50","author":"Marty","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2024080613305710300_bib28","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/jcm.27.9.1965-1968.1989","article-title":"False-positive result in limulus test caused by limulus amebocyte lysate-reactive material in immunoglobulin products","volume":"27","author":"Ikemura","year":"1989","journal-title":"J Clin Microbiol"},{"key":"2024080613305710300_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/BF00311454","article-title":"Clinical and experimental studies of the limulus test after digestive surgery","volume":"25","author":"Kimura","year":"1995","journal-title":"Surg Today"},{"key":"2024080613305710300_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000046037","article-title":"Elevation of blood (1\u21923)-\u03b2-d-glucan concentrations in hemodialysis patients","volume":"89","author":"Kato","year":"2001","journal-title":"Nephron"},{"key":"2024080613305710300_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00268-004-7302-y","article-title":"Combined assessment of \u03b2-d-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients","volume":"28","author":"Takesue","year":"2004","journal-title":"World J Surg"},{"key":"2024080613305710300_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jss.2022.06.072","article-title":"Biofilm formation on central venous catheters: a pilot study","volume":"280","author":"Niemann","year":"2022","journal-title":"J Surg Res"},{"key":"2024080613305710300_bib33","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/517522","article-title":"\u03b2-1,3 glucan as a test for central venous catheter biofilm infection","volume":"195","author":"Nett","year":"2007","journal-title":"J Infect Dis"},{"key":"2024080613305710300_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0668.2005.00333.x","article-title":"(1\u21923)-\u03b2-d-glucans and respiratory health: a review of the scientific evidence","volume":"15","author":"Douwes","year":"2005","journal-title":"Indoor Air"},{"key":"2024080613305710300_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-\u03b2-d-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae071\/58600801\/myae071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/8\/myae071\/58743770\/myae071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/8\/myae071\/58743770\/myae071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:31:59Z","timestamp":1722951119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae071\/7717364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae071","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"type":"print","value":"1369-3786"},{"type":"electronic","value":"1460-2709"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,7,19]]},"article-number":"myae071"}}